Literature DB >> 19605748

A re-evaluation of three putative functional single nucleotide polymorphisms in rheumatoid arthritis.

D Plant, A Barton, W Thomson, X Ke, S Eyre, A Hinks, J Bowes, L J Gibbons, A G Wilson, I Marinou, A W Morgan, S Steer, L J Hocking, D M Reid, P Wordsworth, P Harrison, J Worthington.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19605748     DOI： 10.1136/ard.2008.103572

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  5 in total

1.  Association between the functional MHC2TA -168 A/G polymorphism and susceptibility to rheumatoid arthritis: a meta-analysis.

Authors:  Young Ho Lee; Sang-Cheol Bae
Journal:  Clin Rheumatol       Date:  2015-10-06       Impact factor: 2.980

2.  MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patients.

Authors:  J F Mendoza Rincón; A K Rodríguez Elias; J M Fragoso; G Vargas Alarcón; K Maldonado Murillo; M L Rivas Jiménez; R E Barbosa Cobos; S Jimenez Morales; G Lugo Zamudio; C Tovilla Zárate; J Ramírez Bello
Journal:  Rheumatol Int       Date:  2015-09-08       Impact factor: 2.631

3.  CIITA is not associated with risk of developing rheumatoid arthritis.

Authors:  P G Bronson; P P Ramsay; M F Seldin; P K Gregersen; L A Criswell; L F Barcellos
Journal:  Genes Immun       Date:  2011-01-20       Impact factor: 2.676

Review 4.  Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid arthritis susceptibility.

Authors:  Y H Lee; S-C Bae; J-H Kim; Y H Seo; S J Choi; J D Ji; G G Song
Journal:  Z Rheumatol       Date:  2015-05       Impact factor: 1.372

5.  A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis.

Authors:  Hirofumi Nakaoka; Tailin Cui; Atsushi Tajima; Akira Oka; Shigeki Mitsunaga; Koichi Kashiwase; Yasuhiko Homma; Shinji Sato; Yasuo Suzuki; Hidetoshi Inoko; Ituro Inoue
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.